Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.315 USD | +2.73% | -13.77% | -6.07% |
Mar. 25 | Artelo Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 06 | Top Premarket Gainers | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.24M |
---|---|---|---|---|---|
Net income 2024 * | -14M | Net income 2025 * | -18M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.64
x | P/E ratio 2025 * |
-1.28
x | Employees | 6 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.17% |
Latest transcript on Artelo Biosciences, Inc.
1 day | +2.73% | ||
1 week | -13.77% | ||
Current month | -11.15% | ||
1 month | -12.33% | ||
3 months | -8.04% | ||
6 months | -9.31% | ||
Current year | -6.07% |
Managers | Title | Age | Since |
---|---|---|---|
Gregory Gorgas
CEO | Chief Executive Officer | 61 | 17-04-02 |
Andy Yates
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Steven D. Reich
CTO | Chief Tech/Sci/R&D Officer | - | 18-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Connie Matsui
CHM | Chairman | 70 | 17-05-01 |
Steven Kelly
BRD | Director/Board Member | 59 | 17-05-01 |
Gregory Reyes
BRD | Director/Board Member | 70 | 20-11-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 1.315 | +2.73% | 5,512 |
24-04-18 | 1.28 | -2.66% | 14,181 |
24-04-17 | 1.315 | -9.31% | 45,851 |
24-04-16 | 1.45 | +1.14% | 3,048 |
24-04-15 | 1.434 | -5.99% | 5,311 |
Delayed Quote Nasdaq, April 19, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.07% | 4.13M | |
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |
- Stock Market
- Equities
- ARTL Stock